equivalent dose semaglutide to tirzepatide GLP-1 conversion chart and safe switching guide Switching from tirzepatide to semaglutide

Titration Phase Week 5-8: 0.5 mg once weekly Purpose: Gradually increasing the dose helps improve the bodys tolerance to the medication and enhances its effectiveness in blood sugar control and weight loss

GLPs have been shown to decrease concentrations of total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and FFA, while concurrently increasing high-density lipoprotein cholesterol (HDL-C) levels

Each visit includes a brief intake, clear explanation of what NAD+ is intended to support and a streamlined injection experience in a calm, professional environment

Topical formulations are dermal-delivery products designed for skin application

Consult with a healthcare professional before beginning any supplement regimen